ACAD
ACADIA Pharmaceuticals Inc
20.00$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 280.6% | 269.8% | 639.7% | 360.7% | 736.4% | 915.2% | 4,111.4% | 773.1% | 62.7% | 1,138.6% | 523.4% | 2,333.8% | 77,620.0% | 4,098.4% | 25.4% | 10.5% | 8.2% | 5.8% | 4.7% | 4.0% | 2.0% | 6.3% | 8.5% | 8.3% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -2,233.8% | 100.0% | 100.0% | 74.6% | 89.5% | 91.8% | 94.2% | 95.3% | 96.0% | 98.0% | 93.7% | 91.5% | 91.7% | |
| 225.6% | 352.5% | 237.8% | 229.5% | 509.4% | 281.6% | 607.4% | 766.9% | 3,569.2% | 649.9% | 48.8% | 837.4% | 383.0% | 2,333.8% | 50,501.7% | 121,096.7% | 572.9% | 119.4% | 83.6% | 70.9% | 72.2% | 49.5% | 69.9% | 48.4% | 31.7% | 30.7% | |
| 69.6% | 101.1% | 63.4% | 56.7% | 157.4% | 145.3% | 139.5% | 162.4% | 743.3% | 160.7% | 15.3% | 368.2% | 142.6% | 1,110.9% | 27,290.0% | 148,859.0% | 1,075.9% | 204.2% | 118.7% | 96.0% | 88.0% | 81.8% | 71.4% | 54.1% | 51.0% | 51.2% | |
| 361.3% | 511.4% | 301.2% | 286.2% | 666.8% | 426.8% | 703.1% | 929.3% | 4,312.5% | 810.5% | 64.2% | 1,205.6% | 525.6% | 3,444.7% | 77,791.7% | 269,955.7% | 1,648.7% | 323.7% | 202.4% | 166.9% | 160.2% | 131.3% | 141.3% | 103.8% | 67.4% | 81.9% | |
| -261.3% | -411.4% | -201.2% | -186.2% | -566.8% | -326.8% | -603.1% | -829.3% | -4,212.5% | -710.5% | 35.8% | -1,105.6% | -425.6% | -3,344.7% | -77,691.7% | -269,855.7% | -1,574.1% | -234.1% | -110.6% | -72.7% | -64.9% | -35.2% | -43.2% | -10.1% | 24.1% | 9.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 9.3% | 1.6% | 2.4% | 3.5% | 11.4% | 1.3% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.4% | 1.9% | 1.3% | 1.3% | – | – | – | |
| – | – | – | – | -562.9% | -311.6% | -553.9% | -746.4% | -4,040.5% | -705.5% | 35.9% | -1,101.4% | -424.9% | -3,314.2% | -77,062.5% | -269,037.7% | -1,558.2% | -230.8% | -109.0% | -69.1% | -63.6% | -34.6% | -41.3% | -7.0% | 26.9% | 13.0% | |
| 236.4% | 387.9% | 3.9% | 4.8% | 0.0% | 0.0% | -47.5% | – | -65.6% | – | – | 0.0% | -2.2% | 0.0% | -171.7% | 541.0% | 7.7% | 0.9% | 0.6% | 0.3% | 0.1% | 0.1% | 0.5% | 1.4% | 3.3% | -23.5% | |
| -236.4% | -387.9% | -205.1% | -191.0% | -562.9% | -311.6% | -553.9% | -746.4% | -4,040.5% | -705.5% | 35.9% | -1,101.4% | -424.9% | -3,314.2% | -77,062.5% | -269,578.7% | -1,565.9% | -231.7% | -109.6% | -69.4% | -63.7% | -34.7% | -41.8% | -8.4% | 23.6% | 36.5% | |
| -261.3% | -411.4% | -178.8% | -168.0% | -525.2% | -300.6% | -603.1% | -829.3% | -4,146.9% | -693.2% | 37.3% | -1,087.6% | -423.4% | -3,337.8% | -77,520.0% | -268,795.1% | -1,563.6% | -231.9% | -109.2% | -71.9% | -64.2% | -34.5% | -42.8% | -6.3% | 10.5% | 14.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.